Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters

Atherosclerosis. 1980 Oct;37(2):257-69. doi: 10.1016/0021-9150(80)90011-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoproteins / blood*
  • Bezafibrate
  • Blood Glucose
  • Body Weight
  • Cholesterol / blood
  • Clofibrate / analogs & derivatives*
  • Clofibric Acid / adverse effects
  • Clofibric Acid / analogs & derivatives*
  • Clofibric Acid / pharmacology
  • Esters
  • Fatty Acids / blood
  • Female
  • Humans
  • Insulin / blood
  • Lipids / blood*
  • Lipoproteins / pharmacology*
  • Lipoproteins, LDL / blood
  • Lipoproteins, VLDL / blood
  • Male
  • Middle Aged
  • Triglycerides / blood

Substances

  • Apolipoproteins
  • Blood Glucose
  • Esters
  • Fatty Acids
  • Insulin
  • Lipids
  • Lipoproteins
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Triglycerides
  • Clofibric Acid
  • Cholesterol
  • Clofibrate
  • Bezafibrate